Invion Limited (ASX:IVX) wishes to announce that RMW Cho Group Limited (RMWC), the licensor of the Photosoft(TM) technology, has successfully completed a Phase II prostate cancer trial (ACTRN12621000633886) using a sublingual (under the tongue) formulation of INV043.
The Sage Group Inc. today announced that Chris Rossidis will join the firm as an Executive Director (https://www.linkedin.com/in/chris-rossidis-a5b42a1a/).
KUR International, a global healthcare conglomerate dedicated to furthering science, research, and patient well-being, today announced John Giammona, PhD, has been appointed President and Chief Commercial Officer.
Penta Security, a leading cyber security company and provider of web application security in the Asia-Pacific region, announced that Penta Security’s latest Cloudbric Managed Rules, API Protection, showed outstanding performance in the comparative test audited by The Tolly Group.
Melbourne Skin & Dermatology has introduced a new program focused on state-of-the-art skin cancer detection and treatment. This initiative aims to enhance the clinic’s ability to identify and address skin cancer with the latest technology and methods.
HydRx Wellness is pleased to announce receipt of a Drug Establishment License (DEL) issued by Health Canada in accordance with the Food and Drugs Act and it’s Regulations.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce the appointment of James Williams to its Board as an independent nonexecutive director, effective 16 September 2024.
